Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study

Autor: Konstantinos Gatzoulis, Vassilios Vassilikos, Skevos Sideris, Konstantinos Trachanas, Petros Arsenos, Dimitrios Tsiachris, Emmanouil Simantirakis, Christos-Konstantinos Antoniou, Ioannis Kallikazaros, Iosif Xenogiannis, Michail Vernardos, Ioannis Konstantinou, Konstantinos Triantafyllou, Konstantinos Vlachos, Emmanuel M. Kanoupakis, Panagiotis Korantzopoulos, Athanasios Saplaouras, Nikolaos Fragakis, Antonios Sideris, Ioannis Goudevenos, Efstathios K. Iliodromitis, Panagiota Flevari, Polychronis Dilaveris, Konstantinos Tsimos, Dimitrios Tousoulis
Rok vydání: 2018
Předmět:
Male
Myocardial Infarction
Infarction
030204 cardiovascular system & hematology
Ventricular tachycardia
Sudden cardiac death
Cohort Studies
Electrocardiography
0302 clinical medicine
030212 general & internal medicine
Myocardial infarction
Prospective Studies
Coronary Artery Bypass
education.field_of_study
Ejection fraction
Arrhythmia/Electrophysiology
Cardiac Pacing
Artificial

T wave alternans
Middle Aged
Defibrillators
Implantable

Ventricular Fibrillation
cardiovascular system
Cardiology
Female
medicine.symptom
Cardiology and Cardiovascular Medicine
Adult
medicine.medical_specialty
Arrhythmic risk stratification
Population
Monitoring
Ambulatory

Risk Assessment
03 medical and health sciences
Clinical Research
Internal medicine
medicine
Humans
Programmed ventricular stimulation
cardiovascular diseases
education
Aged
Fibrillation
business.industry
Arrhythmias
Cardiac

Stroke Volume
Preserved ejection fraction
medicine.disease
Editor's Choice
Two-step approach
Death
Sudden
Cardiac

Tachycardia
Ventricular

business
Follow-Up Studies
Zdroj: European Heart Journal
ISSN: 1522-9645
Popis: Aims Sudden cardiac death (SCD) annual incidence is 0.6–1% in post-myocardial infarction (MI) patients with left ventricular ejection fraction (LVEF)≥40%. No recommendations for implantable cardioverter-defibrillator (ICD) use exist in this population. Methods and results We introduced a combined non-invasive/invasive risk stratification approach in post-MI ischaemia-free patients, with LVEF ≥ 40%, in a multicentre, prospective, observational cohort study. Patients with at least one positive electrocardiographic non-invasive risk factor (NIRF): premature ventricular complexes, non-sustained ventricular tachycardia, late potentials, prolonged QTc, increased T-wave alternans, reduced heart rate variability, abnormal deceleration capacity with abnormal turbulence, were referred for programmed ventricular stimulation (PVS), with ICDs offered to those inducible. The primary endpoint was the occurrence of a major arrhythmic event (MAE), namely sustained ventricular tachycardia/fibrillation, appropriate ICD activation or SCD. We screened and included 575 consecutive patients (mean age 57 years, LVEF 50.8%). Of them, 204 (35.5%) had at least one positive NIRF. Forty-one of 152 patients undergoing PVS (27–7.1% of total sample) were inducible. Thirty-seven (90.2%) of them received an ICD. Mean follow-up was 32 months and no SCDs were observed, while 9 ICDs (1.57% of total screened population) were appropriately activated. None patient without NIRFs or with NIRFs but negative PVS met the primary endpoint. The algorithm yielded the following: sensitivity 100%, specificity 93.8%, positive predictive value 22%, and negative predictive value 100%. Conclusion The two-step approach of the PRESERVE EF study detects a subpopulation of post-MI patients with preserved LVEF at risk for MAEs that can be effectively addressed with an ICD. Clinicaltrials.gov identifier NCT02124018
Databáze: OpenAIRE